Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

0.9048 +0.1564 (+20.90%)
Streaming Delayed Price Updated: 1:11 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CASI Pharmaceuticals, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR)
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Changes in Board Governance
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million. 
Via Benzinga
News headline image
CASI Pharmaceuticals Appoints James Huang to Board of Directors
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
CASI Pharmaceuticals Announces Second Quarter 2025 Business and Financial Results
Via ACCESS Newswire
News headline image
CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
Via ACCESS Newswire
News headline image
These stocks are moving in today's pre-market session ↗
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
Top movers in Friday's session ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
What's going on in today's session ↗
Here are the top movers in Monday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Loop Industries (NASDAQ: LOOP) Ignites Paradigm Shift – Twist™ A Breakthrough in Circular Sustainability – More Stocks Inside
Via AB Newswire
Topics Economy
News headline image
Top stock movements in today's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.